Optimal adjuvant therapy and outcomes for early-stage uterine serous and clear cell carcinoma

被引：0
|
作者：
McEachron, Jennifer [1 ]
Zhou, Nancy [1 ]
Bennett, Michelle [1 ]
Hastings, Victoria [2 ]
Kanis, Margaux [2 ]
Gorelick, Constantine [2 ]
Lee, Yi-Chun [1 ]
机构：
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] New York Presbyterian Brooklyn Methodist, Brooklyn, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
421
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [41] Early-Stage Pure and Mixed Endometrial Clear Cell Carcinoma: Outcomes and Patterns of Recurrence
    Chang-Halpenny, C. N.
    Natarajan, S.
    Hwang-Graziano, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S492 - S493
  • [42] An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
    Fader, Amanda Nickles
    Starks, David
    Gehrig, Paola A.
    Secord, Angeles Alvarez
    Frasure, Heidi E.
    O'Malley, David M.
    Tuller, Erin R.
    Rose, Peter G.
    Havrilesky, Laura J.
    Moore, Kathleen N.
    Huh, Warner K.
    Axtell, Allison E.
    Kelley, Joseph L.
    Zanotti, Kristine M.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (02) : 244 - 248
  • [43] Uterine Clear Cell Carcinoma Does Adjuvant Chemotherapy Improve Outcomes?
    Nguyen, Julie M. V.
    Bouchard-Fortier, Genevieve
    Bernardini, Marcus Q.
    Atenafu, Eshetu G.
    Han, Guangming
    Vicus, Danielle
    Ferguson, Sarah E.
    Gien, Lilian T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (01) : 69 - 76
  • [44] The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis
    Qu, X. Melody
    Velker, Vikram M.
    Leung, Eric
    Kwon, Janice S.
    Elshaikh, Mohamed A.
    Kong, Iwa
    Logie, Natalie A.
    Mendez, Lucas C.
    van der Putten, Louis J.
    Donovan, Elysia K.
    Munkarah, Adnan R.
    Wiebe, Ericka M.
    Parra-Herran, Carlos
    Warner, Andrew
    Louie, Alexander, V
    D'Souza, David P.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (02) : 283 - 290
  • [45] Predictors of Outcome in Early-Stage Papillary Serous and Clear Cell Endometrial Cancer
    Dominello, M. M.
    Paximadis, P.
    Kaufman, I.
    Munns, S.
    Dyson, G.
    Konski, A.
    Morris, R.
    Miller, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S421 - S422
  • [46] The impact of adjuvant therapy on survival in uterine clear cell carcinoma patients
    Gockley, A. A.
    Rauh-Hain, J. A.
    Clemmer, J. T.
    Clark, R. M.
    Hall, T. R.
    Goodman, A.
    Borutall, D. M.
    del Carmen, M.
    Growdon, W. B.
    Schorge, J. O.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 35 - 36
  • [47] Adjuvant therapy for Stage IA uterine clear cell carcinoma with no myometrial invasion: a critical review of literature
    Desteli, G. A.
    Dogan, N. U.
    Gursu, T.
    Ayhan, A.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (01) : 17 - 21
  • [48] Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix
    Boruta, DM
    Schorge, JO
    Duska, LA
    Crum, CP
    Castrillon, DH
    Sheets, EE
    GYNECOLOGIC ONCOLOGY, 2001, 81 (01) : 82 - 87
  • [49] Parameters to assess the necessity of adjuvant therapy for early-stage oral squamous cell carcinoma
    Lu, Hsueh-Ju
    Chiu, Yu-Wei
    Peng, Chih-Yu
    Tseng, Hsien-Chun
    Hsin, Chung-Han
    Chuang, Chun-Yi
    Fan, Sheng
    Huang, Wei-Shiou
    Yang, Shun-Fa
    ORAL DISEASES, 2024,
  • [50] Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma
    Thomas, M. Bijoy
    Mariani, Andrea
    Cliby, William A.
    Keeney, Gary A.
    Podratz, Karl C.
    Dowdy, Sean C.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 186 - 189
12345